Quince Therapeutics (QNCX) Institutional Ownership $1.60 +0.08 (+5.26%) Closing price 04:00 PM EasternExtended Trading$1.60 -0.01 (-0.31%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Quince Therapeutics (NASDAQ:QNCX)CurrentInstitutional OwnershipPercentage30.75%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.84MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$27.15K Get QNCX Insider Trade Alerts Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QNCX Institutional Buying and Selling by Quarter Quince Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025Ieq Capital LLC806,780$1.07M0.0%N/A1.828% 5/12/2025Virtu Financial LLC43,332$58K0.0%+48.4%0.098% 4/11/2025Intellectus Partners LLC53,312$71K0.0%N/A0.121% 2/17/2025Two Sigma Investments LP30,341$57K0.0%N/A0.069% 2/17/2025Shay Capital LLC276,799$518K0.1%+60.8%0.629% 2/14/2025Northern Trust Corp50,524$94K0.0%+48.5%0.115% 2/12/2025Geode Capital Management LLC375,932$703K0.0%+10.9%0.854% 2/11/2025Virtu Financial LLC29,204$55K0.0%N/A0.066% 2/5/2025Anfield Capital Management LLC26,656$50K0.0%N/A0.061% 1/24/2025Scharf Investments LLC91,061$170K0.0%N/A0.207% 11/16/2024Geode Capital Management LLC339,125$263K0.0%+24.2%0.784% 8/9/2024Renaissance Technologies LLC483,902$363K0.0%-7.0%1.120% 1/12/2024Scharf Investments LLC91,061$96K0.0%N/A0.212% 7/31/2023Intellectus Partners LLC53,527$81K0.0%N/A0.148% 7/24/2023BML Capital Management LLC1,411,839$2.13M1.9%N/A3.892% 5/11/2023EPIQ Capital Group LLC958,469$1.50M0.8%-9.3%2.642% 4/20/2023Hennion & Walsh Asset Management Inc.31,061$48K0.0%N/A0.086% (Data available from 1/1/2016 forward) QNCX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QNCX shares? During the previous two years, 11 institutional investors and hedge funds held shares of Quince Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($2.13M), Ieq Capital LLC ($1.07M), Geode Capital Management LLC ($703K), Shay Capital LLC ($518K), Renaissance Technologies LLC ($363K), Scharf Investments LLC ($170K), and Northern Trust Corp ($94K).Learn more on Quince Therapeutics' institutional investors. What percentage of Quince Therapeutics' stock is owned by institutional investors? 30.75% of Quince Therapeutics' stock is owned by institutional investors. Learn more on QNCX's institutional investor holdings. Which institutional investors have been buying Quince Therapeutics' stock? Of the 10 institutional investors that purchased Quince Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($1.41M), Ieq Capital LLC ($806.78K), Scharf Investments LLC ($182.12K), Intellectus Partners LLC ($106.84K), Shay Capital LLC ($104.62K), Geode Capital Management LLC ($102.98K), and Virtu Financial LLC ($43.33K). How much institutional buying is happening at Quince Therapeutics? Institutional investors have bought a total of 1,275,576 shares in the last 24 months. This purchase volume represents approximately $1.84M in transactions. Which of Quince Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Quince Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($36.20K). How much institutional selling is happening at Quince Therapeutics? Institutional investors have sold a total of 36,198 shares in the last 24 months. This volume of shares sold represents approximately $27.15K in transactions. Related Companies Aardvark Therapeutics Major Shareholders Olema Pharmaceuticals Major Shareholders Ocugen Major Shareholders Gossamer Bio Major Shareholders Monte Rosa Therapeutics Major Shareholders Corvus Pharmaceuticals Major Shareholders Cartesian Therapeutics Major Shareholders ADC Therapeutics Major Shareholders Aerovate Therapeutics Major Shareholders 2seventy bio Major Shareholders This page (NASDAQ:QNCX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QNCX Stock Alerts